Clinical Trials Sector Losing Appeal

BMI's newest core view is that governments in developed states need to work to maintain the countries' long-term attractiveness as sites for clinical trials, especially as the costs of conducting clinical research is forecast to rise. Data from ClinicalTrials.gov confirms that North America and Western Europe have been the leading destinations in terms of trial numbers; however, trends show that there has been a shift toward conducting trials in Central & Eastern Europe (CEE), as well as increasing rates of patient recruitment for clinical trials in Latin America and Asia. The impetus for this shift includes greater access to drug-naïve patients, low labour

To read the full article, please choose one of the following options: